Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Rahimi, Zohreh ^a,b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN H; HEMOGLOBIN S; HEMOGLOBIN;

ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CLINICAL FEATURE; ENDEMIC DISEASE; GENE FREQUENCY; GENE MUTATION; GENETIC EPIDEMIOLOGY; HEALTH EDUCATION; HEMATOLOGICAL PARAMETERS; HEMOGLOBINOPATHY; HUMAN; MALARIA; PRENATAL DIAGNOSIS; BLOOD; CHEMISTRY; GENETICS; GEOGRAPHY; HEMOGLOBINOPATHIES; IRAN; THALASSEMIA; REVIEW;

GEOGRAPHY; HEMOGLOBINOPATHIES; HEMOGLOBINS; HUMANS; IRAN; THALASSEMIA;

EID: 84880152945     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/803487     Document Type: Article

References (76)

1. Weatherall D. J., Current trends in the diagnosis and management of haemoglobinopathies. Scandinavian Journal of Clinical and Laboratory Investigation 2007 67 1 1 2 2-s2.0-33846979814 10.1080/00365510601051532
2. Old J. M., Screening and genetic diagnosis of haemoglobinopathies. Scandinavian Journal of Clinical and Laboratory Investigation 2007 67 1 71 86 2-s2.0-33846994420 10.1080/00365510601046466
3. Weatherall D. J., The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010 115 22 4331 4336 2-s2.0-77953952024 10.1182/blood-2010-01-251348
4. López C., Saravia C., Gomez A., Hoebeke J., Patarroyo M. A., Mechanisms of genetically-based resistance to malaria. Gene 2010 467 1-2 1 12 2-s2.0-77956880216 10.1016/j.gene.2010.07.008
5. Shear H. L., Grinberg L., Gilman J., Fabry M. E., Stamatoyannopoulos G., Goldberg D. E., Nagel R. L., Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 1998 92 7 2520 2526 2-s2.0-0032189586
6. Williams T. N., Human red blood cell polymorphisms and malaria. Current Opinion in Microbiology 2006 9 4 388 394 2-s2.0-33746317014 10.1016/j.mib.2006. 06.009
7. Weatherall D., Clegg J., Kwiatkowski D., The role of genomics in studying genetic susceptibility to infectious disease. Genome Research 1997 7 10 967 973 2-s2.0-0030663851
8. Raeisi A., Nikpoor F., Kahkha M. R., Faraji L., The trend of malaria in Islamic Republic Iran from 2002 to 2007 Hakim Research Journal 2009 12 35 41
9. Farzinnia B., Saghafipour A., Abai M. R., Malaria situation and anopheline mosquitoes in Qom Province, Central Iran. Iranian Journal of Arthropod-Borne Diseases 2010 4 2 61 67 2-s2.0-79957869221
10. Hanafi-Bojd A. A., Vatandoost H., Philip E., Stepanova E., Abdi A. I., Safari R., Mohseni G. H., Bruhi M. I., Peter A., Abdulrazag S. H., Mangal G., Malaria situation analysis and stratification in Bandar Abbas County, Southern Iran, 2004-2008. Iranian Journal of Arthropod-Borne Diseases 2010 4 1 31 41 2-s2.0-77957377700
11. Ghotbi N., Tsukatani T., Evaluation of the national health policy of thalassaemia screening the Islamic Republic of Iran. Eastern Mediterranean Health Journal 2005 11 3 308 318 2-s2.0-33645310167
12. Nikuei P., Hadavi V., Rajaei M., Saberi M., Hajizade F., Najmabadi H., Prenatal diagnosis for β -thalassemia major in the Iranian Province of Hormozgan. Hemoglobin 2008 32 6 539 545 2-s2.0-57449095232 10.1080/ 03630260802508327
13. Ebrahimzadeh A., Fouladi B., Fazaeli A., High rate of detection of mixed infections of Plasmodium vivax and Plasmodium falciparum in South-East of Iran, using nested PCR. Parasitology International 2007 56 1 61 64 2-s2.0-33847062789 10.1016/j.parint.2006.12.001
14. Soleimanifard S., Akbari M., Sabetghadam M., Saberi S., Malaria situation in Isfahan in the last five years Journal of Isfahan Medical School 2011 29 273 280 2-s2.0-79957965243
15. Strauss B. S., Genetic counseling for thalassemia in the Islamic Republic of Iran. Perspectives in Biology and Medicine 2009 52 3 364 376 2-s2.0-73549098451
16. Weatherall D. J., Clegg J. B., Higgs D. R., Wood W. G., Sriver C. R., Beadet A., Sly W. S., Valle D., The hemoglobinopathies. The Metabolic and Molecular Basis of Inherited Disease 1995 3 New York, NY, USA McGraw-Hill 3417 3484
17. Rahimi Z., Parsian A., Sickle cell disease and venous thromboembolism. Mediterranean Journal of Hematology and Infectious Diseases 2011 3 e2011024
18. Haghshenass M., Ismail-Beigi F., Clegg J. B., Weatherall D. J., Mild sickle cell anaemia in Iran associated with high levels of fetal haemoglobin. Journal of Medical Genetics 1977 14 3 168 171 2-s2.0-0017687597
19. Habibzadeh F., Yadollahie M., Ayatollahie M., Haghshenass M., The prevalence of sickle cell syndrome in South of Iran. Iranian Journal of Medical Sciences 1999 24 32 34
20. Rahgozar S., Poorfathollah A. A., Moafi A. R., Old J. M., β Sgene in Central Iran is in linkage disequilibrium with the Indian-Arab haplotype. The American Journal of Hematology 2000 65 3 192 195
21. Rahimi Z., Muniz A., Mozafari H., Abnormal hemoglobins among Kurdish population of Western Iran: Hematological and molecular features. Molecular Biology Reports 2010 37 1 51 57 2-s2.0-77949261644 10.1007/s11033-009-9516-4
22. Rahimi Z., Akramipour R., Nagel R. L., Ahmadi A. S., Merat A., Bahrehmand F., The β -globin gene haplotypes associated with Hb D-Los Angeles [ β 121(GH4)Glu→Gln] in Western Iran. Hemoglobin 2006 30 1 39 44 2-s2.0-33645087366 10.1080/03630260500454105
23. Rahbar S., Nowzari G., Poosti M., A double heterozygous hemoglobin: hemoglobin O(Indonesia) and hemoglobin D(Punjab) in an individual. The American Journal of Clinical Pathology 1975 64 3 416 420 2-s2.0-0016759054
24. Galehdari H., Salehi B., Azmoun S., Keikhaei B., Zandian K. M., Pedram M., Comprehensive spectrum of the β -thalassemia mutations in Khuzestan, Southwest Iran. Hemoglobin 2010 34 5 461 468 2-s2.0-77956914560 10.3109/03630269.2010.514153
25. Rahimi Z., Akramipour R., Korani S., Nagel R. L., Hb D-punjab [ β 121 (GH4) Glu→Gln]/ β 0-thalassemia [IVSII.1(G→A)] in two cases from an Iranian family: first report. The American Journal of Hematology 2006 81 4 302 303 2-s2.0-33645721627 10.1002/ajh.20537
26. Basmanj M. T., Karimipoor M., Amirian A., Jafarinejad M., Katouzian L., Valaei A., Bayat F., Kordafshari A., Zeinali S., Co-inheritance of hemoglobin D and β -thalassemia traits in three Iranian families: clinical relevance. Archives of Iranian Medicine 2011 14 1 61 63 2-s2.0-78751471605
27. Lorkin P. A., Charlesworth D., Lehmann H., Rahbar S., Tuchinda S., Eng L. I., Two haemoglobins Q, α -74 (EF3) and α -75 (EF4) aspartic acid→histidine. The British Journal of Haematology 1970 19 1 117 125 2-s2.0-0014824740
28. Aksoy M., Gurgey A., Altay C., Kilinc Y., Carstairs K. C., Kutlar A., Chen S. S., Webber B. B., Wilson J. B., Huisman T. H., Some notes about Hb Q-India and Hb Q-Iran. Hemoglobin 1986 10 2 215 219 2-s2.0-0022600791
29. Rahimi Z., Rezaei M., Nagel R. L., Muniz A., Molecular and hematologic analysis of hemoglobin Q-Iran and hemoglobin Setif in Iranian families. Archives of Iranian Medicine 2008 11 4 382 386 2-s2.0-48449104074
30. Rahimi Z., Merat A., Gerard N., Krishnamoorthy R., Nagel R. L., Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in Southern Iran. Human Biology 2006 78 6 719 731 2-s2.0-34447132863
31. Rahimi Z., Karimi M., Haghshenass M., Merat A., β -globin gene cluster haplotypes in sickle cell patients from Southwest Iran. The American Journal of Hematology 2003 74 3 156 160 2-s2.0-0242298665 10.1002/ajh.10422
32. G γ gene expression in sickle cell disease and their association with haplotype and XmnI polymorphic site in South of Iran. Iranian Journal of Medical Sciences 2007 32 4 234 239 2-s2.0-39449137799
33. Yavarian M., Karimi M., Paran F., Neven C., Harteveld C. L., Giordano P. C., Multi centric origin of Hb D-Punjab [ β 121(GH4)Glu→Gln, GAA→CAA]. Hemoglobin 2009 33 6 399 405 2-s2.0-72049122687 10.3109/03630260903344598
34. Rahimi Z., Akramipour R., Vaisi-Raygani A., Nagel R. L., Muniz A., An Iranian child with HbQ-Iran [ α 75 (EF4) Asp→His]/-α 3.7 kb /IVSII.1 G→A: first report. Journal of Pediatric Hematology/Oncology 2007 29 9 649 651 2-s2.0-34548450244 10.1097/MPH.0b013e318142b572
35. Cousens N. E., Gaff C. L., Metcalfe S. A., Delatycki M. B., Carrier screening for β -thalassaemia: a review of international practice. European Journal of Human Genetics 2010 18 10 1077 1083 2-s2.0-77957133346 10.1038/ejhg.2010.90
36. Rachmilewitz E. A., Giardina P. J., How I treat thalassemia. Blood 2011 118 13 3479 3488 2-s2.0-80053364446 10.1182/blood-2010-08-300335
37. Rahimi Z., Raygani A. V., Merat A., Haghshenass M., Gerard N., Nagel R. L., Krishnamoorthy R., Thalassemic mutations in southern Iran. Iranian Journal of Medical Sciences 2006 31 2 70 73 2-s2.0-33744950688
38. Valaei A., Bayat F., Kordafshari A., Zeinali S., Karimipoor M., A novel polymorphism causes a different restriction pattern by RsaI in the β -globin gene cluster: application in prenatal diagnosis. Hemoglobin 2009 33 6 417 421 2-s2.0-72049129702 10.3109/03630260903327817
39. Karimi M., Jamalian N., Yarmohammadi H., Askarnejad A., Afrasiabi A., Hashemi A., Premarital screening for β -thalassaemia in Southern Iran: options for improving the programme. Journal of Medical Screening 2007 14 2 62 66 2-s2.0-34447540222 10.1258/096914107781261882
40. Merat A., Haghshenas M., Pour Z. M., Plonczynski M. W., Harrell A. N., Coleman M. B., Steinberg M. H., β -thalassemia in Southwestern Iran. Hemoglobin 1993 17 5 427 437 2-s2.0-0027364053
41. Karimi M., Yarmohammadi H., Farjadian S., Zeinali S., Moghaddam Z., Cappellini M. D., Giordano P. C., β -thalassemia intermedia from Southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002 26 2 147 154 2-s2.0-0036068650 10.1081/HEM-120005452
42. Yavarian M., Harteveld C. L., Batelaan D., Bernini L. F., Giordano P. C., Molecular spectrum of β -thalassemia in the Iranian Province of Hormozgan. Hemoglobin 2001 25 1 35 43 2-s2.0-0035091652 10.1081/HEM-100103068
43. Najmabadi H., Karimi-Nejad R., Sahebjam S., Pourfarzad F., Teimourian S., Sahebjam F., Amirizadeh N., Karimi-Nejad M. H., The β -thalassemia mutation spectrum in the iranian population. Hemoglobin 2001 25 3 285 296 2-s2.0-0034852845 10.1081/HEM-100105221
44. Derakhshandeh-Peykar P., Akhavan-Niaki H., Tamaddoni A., Ghawidel-Parsa S., Naieni K. H., Rahmani M., Babrzadeh F., Dilmaghani-Zadeh M., Farhud D. D., Distribution of β -thalassemia mutations in the Northern Provinces of Iran. Hemoglobin 2007 31 3 351 356 2-s2.0-34547187703 10.1080/03630260701462030
45. Akhavan-Niaki H., Derakhshandeh-Peykar P., Banihashemi A., Mostafazadeh A., Asghari B., Ahmadifard M., Azizi M., Youssefi A., Elmi M. M., A comprehensive molecular characterization of β thalassemia in a highly heterogeneous population. Blood Cells, Molecules, and Diseases 2011 47 1 29 32 2-s2.0-79956299760 10.1016/j.bcmd.2011.03.005
46. Feizi M. A. H., Feizi A. A. H., Pouladi N., Haghi M., Azarfam P., Molecular spectrum of β -thalassemia mutations in Northwestern Iran. Hemoglobin 2008 32 3 255 261 2-s2.0-45849104275 10.1080/03630260802004145
47. Rahimi Z., Muniz A., Parsian A., Detection of responsible mutations for β thalassemia in the Kermanshah Province of Iran using PCR-based techniques. Molecular Biology Reports 2010 37 1 149 154 2-s2.0-77949272252 10.1007/s11033-009-9560-0
48. Haghi M., Khorshidi S., Feizi M. A. H., Pouladi N., Feizi A. A. H., β -thalassemia mutations in the iranian kurdish population of kurdistan and west azerbaijan provinces. Hemoglobin 2009 33 2 109 114 2-s2.0-67449098139 10.1080/03630260902862020
49. Kiani A. A., Mortazavi Y., Zeinali S., Shirkhani Y., The molecular analysis of β -thalassemia mutations in Lorestan Province, Iran. Hemoglobin 2007 31 3 343 349 2-s2.0-34547230717 10.1080/03630260701459382
50. Salehi R., Fisher C. A., Bignell P. A., Eslami G., Old J. M., Identification of three novel mutations [-41 (A>C), codon 24 (G), and IVS-I-109 (-T)], in a study of β -thalassemia alleles in the Isfahan Region of Iran. Hemoglobin 2010 34 1 115 120 2-s2.0-76449102156 10.3109/ 03630260903554894
51. Miri-Moghaddam E., Zadeh-Vakili A., Rouhani Z., Naderi M., Eshghi P., Feizabad A. K., Molecular basis and prenatal diagnosis of β -thalassemia among Balouch population in Iran. Prenatal Diagnosis 2011 31 8 788 791 2-s2.0-79960564589 10.1002/pd.2767
52. Saleh-Gohari N., Bazrafshani M. R., Distribution of β -globin gene mutations in thalassemia minor population of kerman province, Iran. Iranian Journal of Public Health 2010 39 2 69 76 2-s2.0-77954058615
53. Galanello R., Origa R., β -thalassemia. Orphanet Journal of Rare Diseases 2010 5 1, article 11 2-s2.0-77952432110 10.1186/1750-1172-5-11
54. Thein S. L., Genetic modifiers of β -thalassemia. Haematologica 2005 90 5 649 660 2-s2.0-20344382303
55. Weatherall D. J., Single gene disorders or complex traits: lessons from the thalassaemias and other monogenic diseases. The British Medical Journal 2000 321 7269 1117 1120 2-s2.0-0034605653
56. Rahimi Z., Muniz A., Akramipour R., Tofieghzadeh F., Mozafari H., Vaisi-Raygani A., Parsian A., Haplotype analysis of β thalassemia patients in Western Iran. Blood Cells, Molecules, and Diseases 2009 42 2 140 143 2-s2.0-59349085728 10.1016/j.bcmd.2008.12.001
57. Yavarian M., Karimi M., Bakker E., Harteveld C. L., Giordano P. C., Response to hydroxyurea treatment in Iranian transfusion-dependent β -thalassemia patients. Haematologica 2004 89 10 1172 1178 2-s2.0-6344240976
58. A γ ratio, age at first blood transfusion and clinical features in β -thalassemia patients from Western Iran. Molecular Biology Reports 2010 37 1 159 164 2-s2.0-77949271610 10.1007/s11033-009-9566-7
59. Akbari M. T., Izadi P., Izadyar M., Kyriacou K., Kleanthous M., Molecular basis of thalassemia intermedia in Iran. Hemoglobin 2008 32 5 462 470 2-s2.0-54249084892 10.1080/03630260802341851
60. Hamid M., Mahjoubi F., Akbari M. T., Arab A., Zeinali S., Karimipoor M., Molecular analysis of γ -globin promoters, HS-111 and 3′HS1, in β -thalassemia intermedia patients associated with high levels of Hb F. Hemoglobin 2009 33 6 428 438 2-s2.0-72049119632 10.3109/03630260903336479
61. Higgs D. R., Weatherall D. J., The α thalassaemias. Cellular and Molecular Life Sciences 2009 66 7 1154 1162 2-s2.0-63449137426 10.1007/s00018-008-8529-9
62. Harteveld C. L., Yavarian M., Zorai A., Quakkelaar E. D., van Delft P., Giordano P. C., Molecular spectrum of α -thalassemia in the Iranian population of hormozgan: three novel point mutation defects. The American Journal of Hematology 2003 74 2 99 103 2-s2.0-0141841667 10.1002/ajh.10385
63. Zandian K., Nateghi J., Keikhaie B., Pedram M., Hafezi-Nejad N., Hadavi V., Oberkanins C., Azarkeivan A., Law H., Najmabadi H., α -thalassemia mutations in Khuzestan Province, Southwest Iran. Hemoglobin 2008 32 6 546 552 2-s2.0-57449102117 10.1080/03630260802532780
64. Hossein F., Mohsen R., Mohsen M., Taheri M., α -thalassemia mutations in two provinces of Southern Iran: Fars & Kohkeloye and Bouyer Ahmad. Hemoglobin 2012 36 2 139 143 2-s2.0-84858144204 10.3109/03630269.2012. 657729
65. Tamaddoni A., Hadavi V., Nejad N. H., Khosh-Ain A., Siami R., Aghai-Meibodi J., Almadani N., Oberkanins C., Law H., Najmabadi H., α -thalassemia mutation analyses in mazandaran province, north iran. Hemoglobin 2009 33 2 115 123 2-s2.0-67449098137 10.1080/03630260902817297
66. Hadavi V., Jafroodi M., Hafezi-Nejad N., Moghadam S. D., Eskandari F., Tarashohi S., Pourfahim H., Oberkanins C., Law H., Najmabadi H., α -thalassemia mutations in Gilan Province, North Iran. Hemoglobin 2009 33 3-4 235 241 2-s2.0-68849115951 10.1080/03630260903089029
67. Saleh-Gohari N., Khosravi-Mashizi A., Spectrum of α -globin gene mutations in the Kerman province of Iran. Hemoglobin 2010 34 5 451 460 2-s2.0-77956943192 10.3109/03630269.2010.511587
68. Hadavi V., Taromchi A. H., Malekpour M., Gholami B., Law H., Almadani N., Afroozan F., Sahebjam F., Pajouh P., Kariminejad R., Kariminejad M. H., Azarkeivan A., Jafroodi M., Tamaddoni A., Puehringer H., Oberkanins C., Najmabadi H., Elucidating the spectrum of α -thalassemia mutations in Iran. Haematologica 2007 92 7 992 993 2-s2.0-34548782639 10.3324/haematol.10658
69. Singer S. T., Variable clinical phenotypes of α -thalassemia syndromes. TheScientificWorldJournal 2009 9 615 625 2-s2.0-70349315028 10.1100/tsw.2009.69
70. Zeinali S., Fallah M., Bagherian H., Heterogeneity of hemoglobin H disease in childhood. The New England Journal of Medicine 2011 364 21 2070 2071 2-s2.0-79957444503
71. Cohen A. R., Galanello R., Pennell D. J., Cunningham M. J., Vichinsky E., Thalassemia. Hematology/American Society of Hematology, Education Program 2004 14 34 2-s2.0-14644392013
72. Yavarian M., Karimi M., Zorai A., Harteveld C. L., Giordano P. C., Molecular basis of Hb H disease in southwest Iran. Hemoglobin 2005 29 1 43 50 2-s2.0-14644400560 10.1081/HEM-200047019
73. Ebrahimkhani S., Azarkeivan A., Bayat N., Houry-Parvin M., Jalil-Nejad S., Zand S., Golkar Z., Hadavi V., Imanian H., Oberkanins C., Najmabadi H., Genotype-phenotype correlation in Iranian patients with Hb H disease. Hemoglobin 2011 35 1 40 46 2-s2.0-79952121333 10.3109/03630269.2010.546314
74. Samavat A., Modell B., Iranian national thalassaemia screening programme. The British Medical Journal 2004 329 7475 1134 1137 2-s2.0-8744272457
75. Ghanei M., Adibi P., Movahedi M., Khami M. A., Ghasemi R. L., Azarm T., Zolfaghari B., Jamshidi H. R., Sadri R., Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan. Public Health 1997 111 3 153 156 2-s2.0-0030946160 10.1016/S0033-3506(97)00574-X
76. Christianson A., Streetly A., Darr A., Lessons from thalassaemia screening in Iran. The British Medical Journal 2004 329 7475 1115 1117 2-s2.0-8744238280